Fatigue and symptom-based clusters in post COVID-19 patients: a multicenter, prospective, observational cohort study

Merel E. B. Cornelissen, Lizan D. Bloemsma, , et. al., Journal of Translational Medicine volume 22, Article number: 191 (2024) Abstract Background In the Netherlands, the prevalence of post COVID-19 condition is estimated at 12.7% at 90–150 days…[...]

Read More

COVID-19 symptom load as a risk factor for chronic pain: A national cross-sectional study

Jamie L. Romeiser , Sunitha M. Singh, et. al. https://doi.org/10.1371/ journal.pone.0287554 Abstract Introduction Emerging evidence suggests that a COVID-19 infection with a high initial severity may be associated with development of…[...]

Read More

New-onset chronic musculoskeletal pain following COVID-19 infection fulfil the Fibromyalgia clinical syndrome criteria

Omar Khoja,  Matthew Mulvey, Sarah Astill,  et. al. ,doi: https://doi.org/10.1101/2024.07.10.24310234 ABSTRACT Background New-onset chronic musculoskeletal (MSK) pain (> 3 months duration) is one of the commonest persistent symptoms of Post-COVID syndrome (PCS). There is emerging evidence that the…[...]

Read More

Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study.

O'Kelly B 1,2, Vidal L 2, McHugh T 2, et. al. Brain, Behavior, & Immunity - Health, 03 Jul 2022, 24:100485, https://doi.org/10.1016/j.bbih.2022.100485 PMID: 35814187 PMCID: PMC9250701 Abstract  Background Up to 37.7% of patients experience symptoms beyond 12 weeks after…[...]

Read More